AGP Executive Report
Last update: 5 hours agoInfectious Disease Watch: Israel’s Health Ministry is investigating a suspected Ebola case in a traveler returning from DR Congo, with isolation planned at Sourasky/Ichilov and lab tests underway. Public Health & Safety: Police arrested a suspect in Jerusalem over baby food sedative contamination; lab tests found clonazepam and lorazepam in tampered Prinok puree jars sold at Zol Begadol. Healthcare Access in Conflict: UN humanitarians warned that Gaza aid and winter readiness are being blocked by funding gaps and limits on what can enter Gaza, while also citing strikes that damaged items at the Al Aqsa Hospital compound. Gaza Casualties: Multiple reports say Israeli strikes killed at least five Palestinians in Gaza City, including a crowd near a municipal park and a vehicle in Tel al-Hawa. Education Disruption: All Christian schools in Jerusalem suspended classes starting Sept. 1 after Israel failed to renew entry permits for 70+ teachers and staff, affecting teaching, health services, cleaning, and safety. Drug Pricing/Industry: Teva announced discussions with the Trump administration to lower Medicaid medicine costs in the U.S. Clinical Research: SciSparc reported continued enrollment momentum for its SCI-210 autism trial at Soroka, with 26 children enrolled toward a 60-patient goal.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
